Gilead Sciences
GILD
#105
Rank
A$252.92 B
Marketcap
A$203.84
Share price
1.72%
Change (1 day)
32.52%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): A$15.32 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are A$29.08 Billion. In 2024 the company made an earning of A$0.99 Billion a decrease over its 2023 earnings that were of A$9.84 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$15.32 B1446.77%
2024 A$0.99 B-89.94%
2023 A$9.84 B17.97%
2022 A$8.34 B-29.77%
2021 A$11.88 B395.99%
2020 A$2.39 B-67.66%
2019 A$7.40 B-33.84%
2018 A$11.19 B-42.35%
2017 A$19.42 B-20.87%
2016 A$24.55 B-21.06%
2015 A$31.10 B45.8%
2014 A$21.33 B253.01%
2013 A$6.04 B16.51%
2012 A$5.18 B-1.07%
2011 A$5.24 B-6.71%
2010 A$5.61 B11.75%
2009 A$5.02 B29.5%
2008 A$3.88 B19.11%
2007 A$3.26 B-455.74%
2006 -A$0.92 Billion-154.93%
2005 A$1.66 B76.99%
2004 A$0.94 B-266.16%
2003 -A$0.57 Billion-638.24%
2002 A$0.10 B31.5%
2001 A$80.15 M-242.15%
2000 -A$56.39 Million-40.2%
1999 -A$94.29 Million31.85%
1998 -A$71.52 Million8.73%
1997 -A$65.77 Million27.22%
1996 -A$51.7 Million
1994 -A$49.26 Million26.57%
1993 -A$38.92 Million46.49%
1992 -A$26.57 Million362.5%
1991 -A$5.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.52 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.01 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.38 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.31 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.83 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.73 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.42 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.40 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$33.15 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA